SCHEMBL8660216

SCHEMBL8660216

O=C(O)Cc1ccc(OC(=O)c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 3/20 0.64
▸ KLK1 P06870 2/20 0.64
▸ TMPRSS2 O15393 1/20 0.64
▸ PARP10 Q53GL7 1/20 0.59
▸ SRD5A2 P31213 1/20 0.58
▸ KMT2A Q03164 8/20 0.56
▸ MAPT P10636 4/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ AKR1B1 P15121 1/20 0.55
▸ MEN1 O00255 3/20 0.54
▸ ABCC4 O15439 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ GAA P10253 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ PTGS1 P23219 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ RAB9A P51151 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29697587 0.86 SRD5A2 (0.55) PRSS1KLK1TMPRSS2PARP10SRD5A2
SCHEMBL12199140 0.85 PARP10 (0.62) PARP10SRD5A2KMT2AMAPTTDP1
SCHEMBL725405 0.84 PARP10 (0.77) PRSS1PARP10KMT2AMAPTTDP1
SCHEMBL19924698 0.84 PARP10 (0.61) PARP10KMT2AMAPTTDP1L3MBTL1
SCHEMBL1546405 0.84 PARP10 (0.61) PARP10KMT2AMAPTTDP1L3MBTL1
SCHEMBL4905240 0.84 KMT2A (0.62) PARP10KMT2AMAPTTDP1L3MBTL1
SCHEMBL8210785 0.84 PARP10 (0.61) PARP10SRD5A2KMT2AMAPTTDP1
SCHEMBL10608864 0.84 PARP10 (0.61) PARP10KMT2AMAPTTDP1L3MBTL1
Hydrochloric Acid SCHEMBL16050040 0.82 PARP10 (0.74) PRSS1PARP10KMT2AMAPTTDP1
SCHEMBL9663679 0.82 PARP10 (0.81) PRSS1PARP10KMT2AMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5714606-A OLIGONUCLEOTIDE HAVING RECEPTOR BINDING SITES; ENZYME INHIBITORS, ANTIINFLAMMATORY AGENTS, MEDICAL DIAGNOSIS ISIS PHARMACEUTICALS, INC. (US) 1998-02-03 — — US disclosed
EP-0739335-A4 PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS ISIS PHARMACEUTICALS INC (US) 1997-04-02 — — EP disclosed
EP-0739335-A1 PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS ISIS PHARMACEUTICALS, INC. (US) 1996-10-30 — — EP disclosed
WO-1995018792-A1 PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS ISIS PHARMACEUTICALS, INC. (US) 1995-07-13 — — WO disclosed
EP-0440995-B1 Process for preparing 1-octene SHELL INT RESEARCH (NL) 1994-05-11 — — EP disclosed
EP-0440995-A1 Process for preparing 1-octene SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1991-08-14 — — EP disclosed
US-5030792-A Process for preparing 1-octene SHELL OIL COMPANY (US) 1991-07-09 — — US disclosed
US-4288364-A REACTING A 3-/2-HYDROXYIMINOACETYLAMINO/-2-OXOAZETIDINE WITH AN ORGANIC CARBONATE OR ACYL HALIDE CIBA-GEIGY CORPORATION (US) 1981-09-08 — — US disclosed
EP-0005507-A1 Process for the fragmentation of 3-(2-hydroxyimino-acetylamino)-2-oxo azetidin compounds and compounds obtained thereby CIBA-GEIGY AG (CH) 1979-11-28 — — EP disclosed
Send feedback